219 related articles for article (PubMed ID: 37758406)
1. Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis.
Gulen T
Immunol Allergy Clin North Am; 2023 Nov; 43(4):681-698. PubMed ID: 37758406
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals.
González-de-Olano D; Navarro-Navarro P; Muñoz-González JI; Sánchez-Muñoz L; Henriques A; de-Andrés-Martín A; Peralta-Arjonilla D; Mayado A; Jara-Acevedo M; García-Montero AC; Orfao A; Álvarez-Twose I
Allergy; 2024 Mar; 79(3):711-723. PubMed ID: 37818990
[TBL] [Abstract][Full Text] [Related]
3. Anaphylaxis and Mast Cell Disorders.
Gülen T; Akin C
Immunol Allergy Clin North Am; 2022 Feb; 42(1):45-63. PubMed ID: 34823750
[TBL] [Abstract][Full Text] [Related]
4. Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.
Zaghmout T; Maclachlan L; Bedi N; Gülen T
J Allergy Clin Immunol Pract; 2024 Mar; 12(3):753-761. PubMed ID: 38056692
[TBL] [Abstract][Full Text] [Related]
5. A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis.
Gülen T
Diagnostics (Basel); 2023 Oct; 13(21):. PubMed ID: 37958203
[TBL] [Abstract][Full Text] [Related]
6. Mastocytosis and related entities: a practical roadmap.
Beyens M; Elst J; van der Poorten ML; Van Gasse A; Toscano A; Verlinden A; Vermeulen K; Maes MB; Oude Elberink JNGH; Ebo D; Sabato V
Acta Clin Belg; 2023 Aug; 78(4):325-335. PubMed ID: 36259506
[TBL] [Abstract][Full Text] [Related]
7. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality.
Rama TA; Torrado I; Henriques AF; Sánchez-Muñoz L; Jara-Acevedo M; Navarro-Navarro P; Caldas C; Mayado A; Muñoz-González J; García-Montero A; Mollejo M; Redondo E; Garbán A; Moreira A; Órfão A; Álvarez-Twose I
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):908-919.e4. PubMed ID: 36535520
[TBL] [Abstract][Full Text] [Related]
8. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
Kačar M; Rijavec M; Šelb J; Korošec P
Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
[TBL] [Abstract][Full Text] [Related]
9. Update on idiopathic anaphylaxis.
Calvani M
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27():52-53. PubMed ID: 35080312
[TBL] [Abstract][Full Text] [Related]
10. Mast Cell Disorders In Drug Hypersensitivity.
Bonadonna P; Bonifacio M; Zanotti R
Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084
[TBL] [Abstract][Full Text] [Related]
11. Mimics of Allergy and Angioedema: Scombroid, Mast Cell Activation Disorders, and Hereditary Alpha Tryptasemia.
Thomas EG; Thomas DJ
Immunol Allergy Clin North Am; 2023 Aug; 43(3):553-568. PubMed ID: 37394259
[TBL] [Abstract][Full Text] [Related]
12. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
[TBL] [Abstract][Full Text] [Related]
13. Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis.
Brockow K; Plata-Nazar K; Lange M; Nedoszytko B; Niedoszytko M; Valent P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799959
[TBL] [Abstract][Full Text] [Related]
14. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.
Sprinzl B; Greiner G; Uyanik G; Arock M; Haferlach T; Sperr WR; Valent P; Hoermann G
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671092
[TBL] [Abstract][Full Text] [Related]
15. How to interpret mast cell tests.
Waterfield T; Dyer E; Wilson K; Boyle RJ
Arch Dis Child Educ Pract Ed; 2016 Oct; 101(5):246-51. PubMed ID: 27325614
[TBL] [Abstract][Full Text] [Related]
16. Hymenoptera Allergy and Mast Cell Activation Syndromes.
Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
[TBL] [Abstract][Full Text] [Related]
17. A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders.
Romantowski J; Górska A; Niedoszytko M; Gulen T; Gruchała-Niedoszytko M; Nedoszytko B; Lange M; Brockow K; Arock M; Akin C; Valent P
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535634
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.
Valent P; Akin C; Nedoszytko B; Bonadonna P; Hartmann K; Niedoszytko M; Brockow K; Siebenhaar F; Triggiani M; Arock M; Romantowski J; Górska A; Schwartz LB; Metcalfe DD
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261124
[TBL] [Abstract][Full Text] [Related]
19. Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.
Sordi B; Vanderwert F; Crupi F; Gesullo F; Zanotti R; Bonadonna P; Crosera L; Elena C; Fiorelli N; Ferrari J; Grifoni F; Sciumè M; Parente R; Triggiani M; Palterer B; Mecheri V; Almerigogna F; Santi R; Di Medio L; Brandi ML; Iorno ML; Ciardetti I; Bencini S; Annunziato F; Mannarelli C; Pieri L; Guglielmelli P; Mannelli F; Vannucchi AM
J Allergy Clin Immunol; 2023 Feb; 151(2):485-493.e11. PubMed ID: 36309122
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for anaphylaxis in patients with mastocytosis.
Górska A; Niedoszytko M; Lange M; Chełmińska M; Nedoszytko B; Wasąg B; Słomiński JM; Gruchała-Niedoszytko M; Nowicki R; Jassem E
Pol Arch Med Wewn; 2015; 125(1-2):46-53. PubMed ID: 25578100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
